Press release
Diabetic Kidney Disease Drugs Market 2034: EMA, PDMA, FDA Approvals, Prevalence, Clinical Trials, NDA Approvals, Medication, Revenue, Statistics, Therapies, Companies by DelveInsight
Diabetic Kidney Disease Drugs Market
(Albany, USA) DelveInsight's "Diabetic Kidney Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Diabetic Kidney Disease, historical and forecasted epidemiology as well as the Diabetic Kidney Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report offers a detailed examination of Diabetic Kidney Disease, providing valuable insights into revenue trends, prevalence, and the treatment landscape. It explores key statistics, assessing the current and future market size while evaluating the effectiveness and progress of emerging therapies. Additionally, the report covers the clinical trial landscape, outlining ongoing and upcoming studies that are set to influence the future of Diabetic Kidney Disease treatment. This comprehensive resource is essential for understanding market dynamics and evolving therapeutic options in this space.
To Know in detail about the Diabetic Kidney Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Diabetic Kidney Disease Market Forecast [https://www.delveinsight.com/sample-request/diabetic-kidney-disease-dkd-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Some of the key facts of the Diabetic Kidney Disease Market Report:
*
The Diabetic Kidney Disease market size was vlaued ~USD 7,200 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
*
Key Diabetic Kidney Disease Companies: Curacle Co., Ltd., Boehringer Ingelheim, Bayer, Pfizer, Mitsubishi Tanabe Pharma, PhytoHealth Corporation, Eli Lilly and Company, Korea Otsuka Pharmaceutical, BioStratum, Fresenius Kabi, and others
*
Key Diabetic Kidney Disease Therapies: CU01-1001, BI 685509, BAY94-8862, PF-00489791, Canagliflozin, PH3, LY3016859, Probucol, Pyridorin, Ketosteril Registered , and others
*
The Diabetic Kidney Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Diabetic Kidney Disease pipeline products will significantly revolutionize the Diabetic Kidney Disease market dynamics.
*
According to DelveInsight's estimates, the total prevalent cases of diabetes in the 7MM were approximately 82,858,700 in 2023, with a projected increase over the study period.
*
In 2023, the United States had the highest number of diagnosed prevalent cases of diabetic kidney disease (DKD), with roughly 5,141,000 cases.
*
DKD is predominantly observed in individuals aged 60 and above, accounting for 70% of cases. In the US, age-specific cases of DKD in 2023 were approximately 1,542,000 in the 18-59 age group and around 3,600,000 in the 60+ age group.
Diabetic Kidney Disease Overview
Diabetic Kidney Disease (DKD), also known as diabetic nephropathy, is a serious complication of diabetes that affects kidney function over time. It occurs due to prolonged high blood sugar levels, which damage the kidney's filtration system, leading to protein leakage in the urine (albuminuria) and a gradual decline in kidney function. DKD is a leading cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, significantly impacting patients' quality of life and increasing healthcare costs.
The condition progresses through five stages, from mild kidney damage to complete kidney failure requiring dialysis or transplantation. Risk factors include poor blood sugar control, hypertension, genetic predisposition, and lifestyle factors such as smoking and obesity. Early diagnosis through routine screening of urine albumin levels and kidney function tests is crucial for managing the disease effectively.
Treatment primarily focuses on controlling blood glucose and blood pressure through medications like SGLT2 inhibitors, ACE inhibitors, and ARBs, which have shown to slow disease progression. Additionally, lifestyle modifications, including a balanced diet, regular exercise, and smoking cessation, play a key role in preventing complications. Ongoing clinical trials and research into novel therapies continue to advance treatment options, aiming to improve outcomes for DKD patients.
Get a Free sample for the Diabetic Kidney Disease Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/diabetic-kidney-disease-dkd-market [https://www.delveinsight.com/report-store/diabetic-kidney-disease-dkd-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Diabetic Kidney Disease Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Diabetic Kidney Disease Epidemiology Segmentation:
The Diabetic Kidney Disease market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
*
Total Prevalent Cases of Diabetes in the 7MM
*
Total Prevalent Cases of DKD in the 7MM
*
Diagnosed Prevalent Cases of DKD in the 7MM
*
Age-specific Cases of DKD in the 7MM
*
Stage-specific Cases of DKD in the 7MM
Download the report to understand which factors are driving Diabetic Kidney Disease epidemiology trends @ Diabetic Kidney Disease Epidemiology Forecast [https://www.delveinsight.com/sample-request/diabetic-kidney-disease-dkd-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Diabetic Kidney Disease Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Diabetic Kidney Disease market or expected to get launched during the study period. The analysis covers Diabetic Kidney Disease market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Diabetic Kidney Disease Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Diabetic Kidney Disease Therapies and Key Companies
*
CU01-1001: Curacle Co., Ltd.
*
BI 685509: Boehringer Ingelheim
*
BAY94-8862: Bayer
*
PF-00489791: Pfizer
*
Canagliflozin: Mitsubishi Tanabe Pharma
*
PH3: PhytoHealth Corporation
*
LY3016859: Eli Lilly and Company
*
Probucol: Korea Otsuka Pharmaceutical
*
Pyridorin: BioStratum
*
Ketosteril Registered : Fresenius Kabi
Discover more about therapies set to grab major Diabetic Kidney Disease market share @ Diabetic Kidney Disease Treatment Landscape [https://www.delveinsight.com/sample-request/diabetic-kidney-disease-dkd-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Diabetic Kidney Disease Market Strengths
*
Many major companies are investing in different mechanisms of action for the treatment of DKD, peripherally-acting CB1r blockers, IL-33-neutralizing mAb, ETA receptor antagonists, aldosterone synthase inhibitor (ASi), mineralocorticoid receptor (MR) blockers, and others which will boost the DKD market in the future.
*
A unique trial testing of BI 690517, a selective aldosterone synthase inhibitor along with SGLT2 inhibition, showed positive efficacy, offering the potential for additive kidney benefits while possibly mitigating hyperkalemia risk.
Diabetic Kidney Disease Market Opportunities
*
Personalized medicine, considering the genetic and mechanistic variability, will improve renal and cardiovascular protection in diabetic patients with CKD.
*
The concept of "metabolic memory" in diabetic patients, where prior exposure to elevated blood glucose levels results in enduring detrimental effects despite glycemic control, opens a window of opportunity to develop genetic interventions such as CRISPR-Cas editing to potentially erase this memory and offer novel therapeutic avenues for diabetic kidney disease.
Scope of the Diabetic Kidney Disease Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Diabetic Kidney Disease Companies: Curacle Co., Ltd., Boehringer Ingelheim, Bayer, Pfizer, Mitsubishi Tanabe Pharma, PhytoHealth Corporation, Eli Lilly and Company, Korea Otsuka Pharmaceutical, BioStratum, Fresenius Kabi, and others
*
Key Diabetic Kidney Disease Therapies: CU01-1001, BI 685509, BAY94-8862, PF-00489791, Canagliflozin, PH3, LY3016859, Probucol, Pyridorin, Ketosteril Registered , and others
*
Diabetic Kidney Disease Therapeutic Assessment: Diabetic Kidney Disease current marketed and Diabetic Kidney Disease emerging therapies
*
Diabetic Kidney Disease Market Dynamics: Diabetic Kidney Disease market drivers and Diabetic Kidney Disease market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Diabetic Kidney Disease Unmet Needs, KOL's views, Analyst's views, Diabetic Kidney Disease Market Access and Reimbursement
To know more about Diabetic Kidney Disease companies working in the treatment market, visit @ Diabetic Kidney Disease Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/diabetic-kidney-disease-dkd-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Table of Contents
1. Diabetic Kidney Disease Market Report Introduction
2. Executive Summary for Diabetic Kidney Disease
3. SWOT analysis of Diabetic Kidney Disease
4. Diabetic Kidney Disease Patient Share (%) Overview at a Glance
5. Diabetic Kidney Disease Market Overview at a Glance
6. Diabetic Kidney Disease Disease Background and Overview
7. Diabetic Kidney Disease Epidemiology and Patient Population
8. Country-Specific Patient Population of Diabetic Kidney Disease
9. Diabetic Kidney Disease Current Treatment and Medical Practices
10. Diabetic Kidney Disease Unmet Needs
11. Diabetic Kidney Disease Emerging Therapies
12. Diabetic Kidney Disease Market Outlook
13. Country-Wise Diabetic Kidney Disease Market Analysis (2020-2034)
14. Diabetic Kidney Disease Market Access and Reimbursement of Therapies
15. Diabetic Kidney Disease Market Drivers
16. Diabetic Kidney Disease Market Barriers
17. Diabetic Kidney Disease Appendix
18. Diabetic Kidney Disease Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=diabetic-kidney-disease-drugs-market-2034-ema-pdma-fda-approvals-prevalence-clinical-trials-nda-approvals-medication-revenue-statistics-therapies-companies-by-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/aacr-annual-meeting
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Kidney Disease Drugs Market 2034: EMA, PDMA, FDA Approvals, Prevalence, Clinical Trials, NDA Approvals, Medication, Revenue, Statistics, Therapies, Companies by DelveInsight here
News-ID: 3876671 • Views: …
More Releases from ABNewswire
Dynamic Roofing Concepts Offers Roof Replacement in Brandon, FL as Aging Roofs I …
Brandon, FL - Homeowners in Brandon, Florida, are facing increased pressure to replace aging roofs as insurance companies tighten coverage requirements. Dynamic Roofing Concepts provides roof replacement in Brandon, FL [https://www.dynamicroofingconcepts.com/] and has seen increased demand as local homeowners face pressure from insurance companies to replace aging roofs.
In Florida, most homeowners are aware that old roofs are more vulnerable to wind and water damage. Insurance providers have responded by requiring…
How to Know When It's Time for an Exterminator: Evo Foam Pest Control's Expert G …
Not sure when to contact an exterminator? Evo Foam Pest Control explains the common signs of pest problems in Austin and why timely intervention is essential.
Austin, TX - Pest infestations can occur at any time, leaving homeowners in Austin, TX, wondering when it's necessary to call an exterminator Austin TX. With numerous pests, including ants, rodents, and termites, threatening the comfort of homes, it's essential to recognize the signs that…
Palm Coast Pest Control Shows How Eco-Friendly Pest Control Keeps Jupiter, FL Ho …
Discover how Palm Coast Pest Control uses eco-friendly solutions to protect Jupiter, FL homes from pests while maintaining a healthy, chemical-free environment.
Jupiter, FL - As residents of Jupiter, FL, seek effective and sustainable solutions to pest problems, Palm Coast Pest Control stands out as a trusted provider of eco-friendly pest control services. The company has earned a reputation for its commitment to keeping homes safe, healthy, and pest-free while also…
Metro Heat and Air OKC Stands Out for Expertise, Reliability, and Customer Care …
Metro Heat and Air OKC is known for delivering top-notch air conditioning services in Edmond, OK, combining professionalism, trustworthiness, and outstanding customer service.
Edmond, OK - In Edmond, OK, residents seeking reliable air conditioning services turn to Metro Heat and Air OKC, a trusted HVAC contractor [https://www.google.com/maps?cid=12790181814582558152] committed to delivering exceptional comfort solutions. The company has earned a solid reputation in the area for its high level of expertise, dependability, and…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
